Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 3.340
+0.070 (2.14%)
At close: Dec 19, 2025
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.24 billion as of December 19, 2025. Its market cap has decreased by -31.29% in one year.
Market Cap
1.24B
Enterprise Value
1.16B
Revenue
9.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.34
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.24B, an increase of 223.42%. That is a compound annual growth rate of 31.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.24B | -7.12% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | 384.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.46B |
| Pro Medicus | 22.79B |
| Cochlear | 16.85B |
| Sonic Healthcare | 11.16B |
| Ramsay Health Care | 7.96B |
| Ansell | 5.06B |
| Telix Pharmaceuticals | 4.01B |
| Mesoblast | 3.71B |